👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

REFILE-Japanese stocks jump on signs of coronavirus slowdown

Published 06/04/2020, 08:49
Updated 06/04/2020, 10:42
REFILE-Japanese stocks jump on signs of coronavirus slowdown
JP225
-
ESH25
-
TOPX
-
4061
-
4901
-
9433
-
9437
-
ICOMS.T
-
ISHIP.T
-
ITEQP.T
-
9434
-

(Adds dropped letters 'DS' to company name in paragraph 6)
SYDNEY, April 6 (Reuters) - Japanese shares rose on Monday,
boosted by a slowdown in COVID-19 deaths and new cases in global
hotspots including New York and Italy, as uncertainty over a
potential lockdown in Tokyo kept some investors on the
sidelines.
The benchmark Nikkei average .N225 gained 4.2% to
18,576.30, its highest close in nearly a week, tracking sharp
gains in U.S. stock futures.
E-mini futures for the S&P 500 index ESc1 climbed as much
as 4.2% in Asian trade after U.S. President Donald Trump
expressed hope the United States was seeing a "levelling off" of
the epidemic in hotspots. Also helping was the fact that Italy reported its lowest
daily COVID-19 death toll for more than two weeks on Sunday as
authorities began to look ahead to a second phase of the battle
against the virus once a lockdown imposed a month ago is eased.
The Tokyo bourse appeared to have shrugged off Friday's
shocking U.S. jobs data, which showed nonfarm payrolls fell by
701,000 last month. "The number of new coronavirus infections and deaths -
that's what the market cares about the most for now," said
Masahiro Ichikawa, senior strategist at Sumitomo Mitsui DS Asset
Management.
Japanese Prime Minister Shinzo Abe will impose a state of
emergency as early as Tuesday in a bid to stop the coronavirus
spreading, multiple media reported, as the cumulative number of
infections topped 1,000 in Tokyo alone.
Abe will likely announce his plans later on Monday, the
Yomiuri newspaper said, while the Kyodo news agency said new
measures would likely come into force on Wednesday. Some analysts predict the government could declare a state
of emergency to coincide with the announcement of an economic
stimulus package on Tuesday. However, traders said most long-only investors seemed to be
still watching from the sidelines.
"I have a feeling like shorts were getting squeezed," said
Takeo Kamai, head of executions services at CLSA in Tokyo,
referring to the reason the Nikkei extended gains in late
afternoon trade.
Overall trading was subdued, with the volume of shares
traded on the main board valued at 2.70 trillion yen ($24.7
billion), well below its average over the last 20 days of 3.54
trillion yen.
The broader Topix .TOPX advanced 3.9% to 1,376.30, with
all of the 33 sector sub-indexes on the exchange finishing in
positive territory.
Cyclical sectors outperformed defensives, with sea transport
.ISHIP.T and transport equipment .ITEQP.T sectors climbing
7.1% and 6.1%, respectively.
Information and communication .ICOMS.T sector added 5.7%
on hopes for growing demand for data as more people work from
home or stay at home due to the pandemic.
NTT Docomo Inc 9437.T jumped 6.8%, while KDDI Corp
9433.T and SoftBank Corp 9434.T gained 5.8% and 7.0%,
respectively.
Fujifilm Holdings Corp 4901.T surged 7.0% to a record high
after Reuters and other media said Japan was planning to boost
stockpiles of the Avigan anti-flu drug, which is being tested as
a treatment for COVID-19 in China. Denka Co Ltd 4061.T , which produces the raw chemicals used
to make Avigan, soared 19.5% to its daily-limit high.

($1 = 109.1700 yen)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.